2023 Insurance Coverage and Processing Packaging 
PharmaTech
JUNE 10, 2025
It provides evidence-based recommendations on the use of vaccines for children and adults, informs decisions about insurance coverage, and helps determine eligibility for publicly funded programs such as Vaccines for Children (VFC). ACIP plays a foundational role in shaping immunization policy in the US. BIO President and CEO John F.
Express Pharma
MARCH 16, 2025
On the global stage, AI and Machine Learning (ML) drove drug discovery and process optimisation, especially as large-scale pharma companies adopted AI for precision medicine. Building sophisticated laboratories, recruiting scientific talent, and collaborating with global research institutions are essential steps in this process.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Putting Patients First Blog
FEBRUARY 1, 2024
Since it is likely this appropriations package will be one of the last meaningful pieces of legislation before the November elections, other policy priorities may be added to that final legislation as it gets closer to passage. 5378 More Transparency, Lower Costs Act in December 2023. The House passed H.R.
Pharmaceutical Technology
JUNE 12, 2025
In 2023, SpliceBio signed a licensing agreement with Spark Therapeutics, allowing the latter to use its protein splicing platform and develop a gene therapy for an undisclosed inherited renal disease. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.
Putting Patients First Blog
MARCH 18, 2024
The NHC supports the development and use of processes and tools that enhance beneficiary experience, making interactions with the MPPP smoother and more intuitive for all beneficiaries. Similarly, updating the Explanation of Benefits to include visual aids and examples will clarify MPPP’s impact on cost-sharing and coverage.
Putting Patients First Blog
MARCH 18, 2024
The NHC supports the development and use of processes and tools that enhance beneficiary experience, making interactions with the MPPP smoother and more intuitive for all beneficiaries. Similarly, updating the Explanation of Benefits to include visual aids and examples will clarify MPPP’s impact on cost-sharing and coverage.
Express Pharma
JANUARY 12, 2024
Further, introduction of the Scheme for Promotion of R&D and Innovation in Pharma Med Tech Sector (PRIP) in September 2023 showcases the focus on creating an ecosystem for innovation and research. Due to the multiplicity of regulatory processes and multiple regulators, undertaking operations become complex and time consuming.
Expert insights. Personalized for you.
85 
Let's personalize your content